Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Potential drug-food interactions with pomegranate juice.

Summers KM.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1472-3. Epub 2006 Jun 27. No abstract available.

PMID:
16804094
3.

Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.

Hidaka M, Okumura M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Setoguchi N, Arimori K.

Drug Metab Dispos. 2005 May;33(5):644-8. Epub 2005 Jan 26.

4.

Effect of 2 weeks' consumption of pomegranate juice on the pharmacokinetics of a single dose of midazolam: an open-label, randomized, single-center, 2-period crossover study in healthy Japanese volunteers.

Misaka S, Nakamura R, Uchida S, Takeuchi K, Takahashi N, Inui N, Kosuge K, Yamada S, Watanabe H.

Clin Ther. 2011 Feb;33(2):246-52. doi: 10.1016/j.clinthera.2011.02.012.

PMID:
21497708
5.

Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats.

Nagata M, Hidaka M, Sekiya H, Kawano Y, Yamasaki K, Okumura M, Arimori K.

Drug Metab Dispos. 2007 Feb;35(2):302-5. Epub 2006 Nov 28.

6.

Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence.

Srinivas NR.

Eur J Drug Metab Pharmacokinet. 2013 Dec;38(4):223-9. doi: 10.1007/s13318-013-0137-x. Epub 2013 May 15.

PMID:
23673492
7.

Drug interaction potentials among different brands of grapefruit juice.

Uesawa Y, Mohri K.

Pharmazie. 2008 Feb;63(2):144-6.

PMID:
18380401
8.

[Fruit and berries--interactions with drugs].

Molden E, Spigset O.

Tidsskr Nor Laegeforen. 2007 Dec 13;127(24):3218-20. Norwegian.

9.

Transient inhibition of cyp3a in rats by star fruit juice.

Hidaka M, Okumura M, Ogikubo T, Kai H, Fujita K, Iwakiri T, Yamasaki K, Setoguchi N, Matsunaga N, Arimori K.

Drug Metab Dispos. 2006 Mar;34(3):343-5. Epub 2005 Dec 2.

10.

Grapefruit juice, a glass full of drug interactions?

Kirby BJ, Unadkat JD.

Clin Pharmacol Ther. 2007 May;81(5):631-3.

PMID:
17438537
11.

Effect of pomegranate juice on the pharmacokinetics of nitrendipine in rabbits.

Voruganti S, Rapolu K, Tota S, Yamsani SK, Yamsani MR.

Eur J Drug Metab Pharmacokinet. 2012 Jun;37(2):77-81. doi: 10.1007/s13318-011-0075-4. Epub 2011 Nov 22.

PMID:
22101410
12.

Possible interaction between pomegranate juice and warfarin.

Jarvis S, Li C, Bogle RG.

Emerg Med J. 2010 Jan;27(1):74-5. doi: 10.1136/emj.2007.055855.

PMID:
20029019
13.

Potentially significant versus clinically significant drug interactions: pomegranate juice as a case in point.

Andrade C.

J Clin Psychiatry. 2014 Apr;75(4):e292-3. doi: 10.4088/JCP.14f09112. Review.

14.

Potential interaction between pomegranate juice and warfarin.

Komperda KE.

Pharmacotherapy. 2009 Aug;29(8):1002-6. doi: 10.1592/phco.29.8.1002.

PMID:
19637955
15.

[Grapefruit juice interactions with psychotropic drugs: advantages and potential risk].

Pawełczyk T, Kłoszewska I.

Przegl Lek. 2008;65(2):92-5. Review. Polish.

PMID:
18663908
16.

White and colored grapefruit juice produce similar pharmacokinetic interactions.

Uesawa Y, Abe M, Mohri K.

Pharmazie. 2008 Aug;63(8):598-600.

PMID:
18771009
17.

Intestinal drug transporter expression and the impact of grapefruit juice in humans.

Glaeser H, Bailey DG, Dresser GK, Gregor JC, Schwarz UI, McGrath JS, Jolicoeur E, Lee W, Leake BF, Tirona RG, Kim RB.

Clin Pharmacol Ther. 2007 Mar;81(3):362-70. Epub 2007 Jan 10.

PMID:
17215845
18.

[Possible interaction between pomegranate juice and warfarin].

Andersson M, Lindh J.

Lakartidningen. 2012 Feb 29-Mar 13;109(9-10):483. Swedish. No abstract available.

PMID:
22530414
19.

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Bailey DG, Dresser G, Arnold JM.

CMAJ. 2013 Mar 5;185(4):309-16. doi: 10.1503/cmaj.120951. Epub 2012 Nov 26. Review. No abstract available.

20.

Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.

Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, Watkins PB.

Am J Clin Nutr. 2008 Apr;87(4):863-71.

Supplemental Content

Support Center